Aversion therapy is a behavioral treatment that pairs an unwanted habit or behavior with something physically unpleasant, like nausea or discomfort, until the person develops an automatic negative reaction to the behavior itself. It’s rooted in classical conditioning, the same type of learning that made Pavlov’s dogs salivate at the sound of a bell. Instead of creating a positive association, aversion therapy creates a negative one. The technique has been used most commonly for alcohol dependence and smoking, though its history includes deeply controversial applications that have led to bans in several jurisdictions.
How Classical Conditioning Drives It
Classical conditioning is an unconscious process where an automatic response becomes linked to a specific stimulus through repeated pairing. In everyday life, this happens naturally: the smell of a food that once made you sick can trigger nausea years later, even if the food is perfectly fine. Aversion therapy exploits this same mechanism on purpose.
In a treatment session, the therapist pairs the target behavior (drinking alcohol, for example) with an unpleasant physical experience (severe nausea). After enough repetitions, the brain begins associating the behavior itself with the discomfort, even when the artificial trigger is no longer present. The speed of this learning depends on how intense the unpleasant stimulus is and how closely it’s timed with the behavior. A gap of even a few seconds between the two can weaken the association significantly.
There’s an important limitation built into the biology. If the person encounters the target behavior repeatedly without the unpleasant consequence, the learned aversion gradually fades. This is called extinction, and it’s one reason aversion therapy often requires booster sessions to maintain its effects. That said, even after a long period of extinction, the aversion can reappear quickly if the pairing is reintroduced.
Chemical Aversion for Alcohol Dependence
The most widely studied form of aversion therapy uses medication that makes alcohol consumption intensely unpleasant. The medication blocks the body’s ability to fully process alcohol, causing a buildup of a toxic byproduct that triggers sweating, palpitations, facial flushing, nausea, dizziness, and a drop in blood pressure. The experience is so uncomfortable that patients develop a conditioned aversion to the taste and smell of alcohol.
Historical data on this approach is surprisingly robust. In one large study of over 4,000 patients treated at a hospital in Seattle during the 1940s, 60% remained abstinent for at least one year and 42% stayed completely abstinent over longer follow-up periods. A separate study found a 51% success rate. More recent work at a Portland hospital reported one-year abstinence rates of 63%, with outcomes varying significantly by the patient’s social stability: married, employed patients achieved abstinence rates as high as 73%, while disabled patients on Medicare had rates closer to 36%.
These numbers compare favorably to many other alcohol treatments, but they come with caveats. The patients who do well in aversion therapy tend to be more socially stable to begin with, which makes it hard to separate the therapy’s effect from the patient’s existing advantages. Deliberate pairing of the medication with alcohol in a clinical setting to provoke the reaction is no longer a recommended practice, reflecting a shift toward using the medication as a deterrent rather than as a conditioning tool.
Rapid Smoking for Cigarette Addiction
For smoking cessation, the most common aversive technique is called rapid smoking. In a typical session, you’re asked to take a puff every six to ten seconds, far faster than normal smoking. This continues for three minutes, or until you’ve consumed three cigarettes, or until you physically can’t continue. After a rest period, the cycle repeats two or three more times.
The goal is to overwhelm the pleasurable associations with cigarettes by flooding the body with nicotine and smoke until the experience becomes genuinely sickening. Over multiple sessions, the sight, smell, and taste of cigarettes begin triggering disgust rather than craving. A Cochrane review examined the evidence across multiple trials and found some support for the technique, though the overall quality of the studies was limited.
Electric Shock and Other Aversive Stimuli
Historically, mild electric shocks were another common tool in aversion therapy. A patient might be shown images related to the unwanted behavior while receiving a brief, uncomfortable shock. The idea was identical to chemical aversion: pair the behavior with discomfort until the brain automatically links the two.
This approach has largely fallen out of mainstream practice. The discomfort was harder to calibrate than chemical methods, the ethical concerns were significant, and the evidence for lasting effectiveness was weak compared to alternatives. The FDA does still list aversive conditioning devices as a recognized medical device category, but their clinical use is extremely limited today.
The Conversion Therapy Controversy
Aversion therapy’s most damaging legacy is its use in attempts to change sexual orientation. From the mid-20th century through the 1970s and beyond, some practitioners used electric shocks, nausea-inducing drugs, and other aversive stimuli on gay and lesbian patients, often under coercion or with patients who felt pressured by family or social expectations.
The American Psychological Association has formally concluded that there is insufficient evidence to support the use of any psychological intervention to change sexual orientation. The APA advises against approaches that portray homosexuality as a mental illness or developmental disorder and has highlighted concerns about benefit, harm, justice, and respect for people’s rights and dignity. These efforts are now broadly recognized as harmful, not therapeutic.
Legislative bans have followed. California, New Jersey, Oregon, Illinois, Washington D.C., and the Canadian province of Ontario passed laws prohibiting licensed mental health professionals from performing conversion therapy on minors, and many additional jurisdictions have since enacted similar protections. The distinction matters: these laws don’t restrict aversion therapy for substance dependence or other conditions. They specifically target its use in sexual orientation change efforts, reflecting the scientific consensus that such efforts are both ineffective and damaging.
Why It’s Rarely a First-Line Treatment
Even in areas where aversion therapy has shown measurable results, like alcohol dependence, it’s rarely the first option a clinician recommends today. Several factors explain this. The experience is inherently unpleasant, which makes patient willingness and retention a challenge. The conditioned aversion tends to weaken over time without reinforcement, meaning the effects aren’t permanent. And for most conditions, alternative approaches like cognitive behavioral therapy, motivational interviewing, and medication-assisted treatment offer comparable or better outcomes with fewer ethical concerns.
Aversion therapy works best, when it works at all, as one component within a broader treatment plan rather than a standalone intervention. Patients with strong social support, stable employment, and genuine motivation tend to get the most benefit. For someone without those advantages, the conditioning alone is rarely enough to sustain long-term behavior change.